Ikarian Capital »

Sana Biotechnology shares owned by Ikarian Capital

Quarter-by-quarter ownership of Sana Biotechnology (SANA) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Sana Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Sana Biotechnology held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sana Biotechnology by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.4M 1.3M 4.16
2024-06-30 $4.4M 8.0k 546.00

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Sana Biotechnology

Flagship Ventures Management
Vanguard Group
BlackRock
BlackRock
Baillie Gifford & Co
Canada Pension Plan Investment Board
State Street Corporation
Capital World Investors
Geode Capital Management
Crestline Management
T. Rowe Price Associates
Alphabet
Baker Bros. Advisors
Morgan Stanley
Boxer Capital

View all funds holding Sana Biotechnology